Delivery Order SPE2DR25D2003-SPE2DR26FR00Z
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Xyosted 100 mg/0.5 mL auto-injector units, valued at $1,384.82 under a firm fixed price contract structure. This delivery order represents a competitive award with no set-aside designation and is scheduled for completion by September 17, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Xyosted 100 mg/0.5 mL auto-injector units, valued at $1,078.57 with a firm fixed price structure. This is a competitively awarded, non-set-aside contract with an ultimate completion date of October 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,372.14 to AmerisourceBergen Drug Corp for the supply of Xyosted 50 mg/0.5 mL auto-injector units. This competitively awarded, non-set-aside contract was executed on November 13, 2025, with an ultimate completion date of November 14, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The firm fixed price delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical...
- The Defense Logistics Agency awarded a $1,711.16 delivery order to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 mL auto-injector units on September 5, 2025, with an ultimate completion date of September 8, 2025. This firm fixed-price contract represents a non-set-aside competitive award for pharmaceutical supply to support federal medical procurement needs. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Xyosted 75 mg/0.5 mL auto-injector units valued at $1,954.96. This is a firm fixed price delivery order with an ultimate completion date of August 21, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Xyosted 100 mg/0.5 mL auto-injectors valued at $3,328.44. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order has an ultimate completion date of November 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 mL auto-injector pharmaceutical product with a ceiling value of $2,444.49. This competitively awarded, firm fixed price delivery order is set to be completed by September 9, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single transaction within the broader federal medical supply procurement landscape...
- The Defense Logistics Agency awarded a delivery order valued at $1,051.80 to AmerisourceBergen Drug Corp for Xyosted 75 mg/0.5 mL auto-injector syringes. This non-competitive, firm fixed-price delivery order was awarded on November 18, 2025, with an ultimate completion date of November 19, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a delivery order, this award represents a specific task issued under a larger contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,577.70 to AmerisourceBergen Drug Corp for Xyosted 75 mg/0.5 ml auto-injector supplies, with a completion date of December 11, 2025. This non-competitive delivery order is issued under a firm fixed-price contract structure and represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with DLA. The product will be performed and delivered from the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $1,257.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 mL auto-injector supplies on December 3, 2025, with completion targeted for December 4, 2025. This non-set-aside award represents a small-value transaction under AmerisourceBergen's broader relationship with DLA for pharmaceutical and medical supply distribution. The delivery location is the vendor's corporate office in Conshohocken, Pennsylvania. This delivery...
- SPE2DR25D2003Indefinite Delivery Contract
- SPE2DR25D2003-SPE2DR26FR00ZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 mL auto-injector supplies, with a ceiling value of $1,745.04 and a firm fixed price structure. The contract, awarded on December 4, 2025, with an ultimate completion date of December 5, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award involves no set-aside designation and represents a competitively awarded delivery order under AmerisourceBergen's existing contract vehicle. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen serves critical federal medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with a demonstrated capability to fulfill competitively awarded orders across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 12/3/25 |